Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Gastrointestinal Motility Disorders

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psychogenic (Functional) Movement Disorders.

Continuum (Minneapolis, Minn.)·2019

Same author

Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.

Parkinsonism & related disorders·2019

Same author

Young-onset Parkinson's disease: Its unique features and their impact on quality of life.

Parkinsonism & related disorders·2019

Same author

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?

Frontiers in neurology·2019

Same author

Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.

Journal of the neurological sciences·2019

Same author

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Molecular genetics & genomic medicine·2019

Search research articles

Related Experiment Video

Updated: May 25, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Iron dysregulation in movement disorders.

Petr Dusek¹, Joseph Jankovic, Weidong Le

¹Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

Neurobiology of Disease

|January 24, 2012

Summary

Neurodegeneration with brain iron accumulation (NBIA) and other movement disorders involve iron dysregulation. This review updates genetics, mechanisms, diagnosis, and treatment, proposing a new NBIA classification.

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Area of Science:

Neuroscience
Genetics
Biochemistry

Background:

Iron is vital for brain functions including energy production, DNA synthesis, and myelination.
Neurodegeneration with brain iron accumulation (NBIA) encompasses genetic disorders linked to iron metabolism or phospholipid metabolism.
Increased brain iron is also observed in common neurodegenerative diseases like Parkinson's and Huntington's disease.

Purpose of the Study:

To review recent advances in the genetics, pathogenic mechanisms, diagnosis, and treatment of movement disorders associated with brain iron dysregulation.
To propose a novel classification system for NBIA disorders.

Main Methods:

Literature review of genetic studies, mechanistic investigations, and clinical trials.
Analysis of existing classifications and proposal of a new framework for NBIA.

Main Results:

NBIA disorders arise from mutations affecting iron metabolism, phospholipid metabolism, or lysosomal pathways.
Dysregulated iron handling, including impaired lysosomal recycling and mitochondrial utilization, contributes to neurodegeneration.
Common movement disorders and restless legs syndrome also show altered brain iron levels.

Conclusions:

Brain iron dysregulation is a common theme in various neurological disorders, from rare NBIAs to common movement disorders.
Understanding these mechanisms is crucial for developing targeted diagnostics and therapeutics.
A revised classification of NBIA is proposed to better categorize these complex genetic conditions.